PVLA R&D Expenses
Palvella Therapeutics Inc · R&D Expenses
PVLA R&D Expenses
Latest reported$35.46Mperiod ending
PVLA TTM R&D Expenses ($40.44M → $35.46M)
TTM R&D Expenses
High-resolution chart · PNG
PVLA r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 35,456,000 | |
| 28,101,000 | |
| 22,841,000 | |
| 18,263,000 | |
| 14,931,000 | |
| 11,255,000 | |
| 8,165,000 | |
| 10,076,000 | |
| 16,475,000 | |
| 28,603,000 | |
| 40,438,000 |